The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans
Open accessAbstract
Mutant Pik3ca gives rise to venous malformations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Finding of Rare Disease Genes (FORGE) Canada Consortium, Rivière, J.-B., Mirzaa, G. M., O'Roak, B. J., Beddaoui, M., Alcantara, D., Conway, R. L., St-Onge, J., Schwartzentruber, J. A., Gripp, K. W., et al. (2012) · Nature Genetics · doi:10.1038/ng.2331 · Cited by 741 · cited 1×
“PIK3CA has recently been shown to undergo a similar range of activating mutations in non-cancerous disease conditions, such as in a spectrum of regional overgrowth disorders (3-6) (which have now been designated under the umbrella term PIK3CA-Related Overgrowth Spectrum (PROS) disease (7)) and in isolated (i.”
BackgroundKim, I., Kim, H. G., So, J.-N., Kim, J. H., Kwak, H. J., & Koh, G. Y. (2000) · Circulation Research · doi:10.1161/01.res.86.1.24 · Cited by 649
Duration of Rapamycin Treatment Has Differential Effects on Metabolism in Mice
Fang, Y., Westbrook, R., Hill, C., Boparai, R. K., Arum, O., Spong, A., Wang, F., Javors, M. A., Chen, J., Sun, L. Y., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.008 · Cited by 195
Cited by
Vascular heterogeneity and specialization in development and disease
Potente, M., & Mäkinen, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.36 · Cited by 653
Therapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Venot, Q., Blanc, T., Rabia, S. H., Berteloot, L., Ladraa, S., Duong, J.-P., Blanc, E., Johnson, S. C., Hoguin, C., Boccara, O., et al. (2018) · Nature · doi:10.1038/s41586-018-0217-9 · Cited by 589
Materials and structural designs of stretchable conductors
Matsuhisa, N., Chen, X., Bao, Z., & Someya, T. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00814k · Cited by 566
ISSVA Classification of Vascular Anomalies and Molecular Biology
Kunimoto, K., Yamamoto, Y., & Jinnin, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042358 · Cited by 309
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy
Al-Olabi, L., Polubothu, S., Dowsett, K., Andrews, K. A., Stadnik, P., Joseph, A. P., Knox, R., Pittman, A., Clark, G., Baird, W., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98589 · Cited by 292
Self-citationCancer-Associated PIK3CA Mutations in Overgrowth Disorders
Madsen, R. R., Vanhaesebroeck, B., & Semple, R. K. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.08.003 · Cited by 276
Self-citationTherapeutic base editing of human hematopoietic stem cells
Zeng, J., Wu, Y., Ren, C., Bonanno, J., Shen, A. H., Shea, D., Gehrke, J. M., Clement, K., Luk, K., Yao, Q., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0790-y · Cited by 283
Kapnisi, M., Mansfield, C., Marijon, C., Guex, A. G., Perbellini, F., Bardi, I., Humphrey, E. J., Puetzer, J. L., Mawad, D., Koutsogeorgis, D. C., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201800618 · Cited by 278
Self-citationOkkenhaug, K., Graupera, M., & Vanhaesebroeck, B. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0716 · Cited by 264
Self-citationHuman hepatocyte transplantation for liver disease: current status and future perspectives
Iansante, V, Mitry, R. R., Filippi, C., Fitzpatrick, E., & Dhawan, A. (2018) · Pediatric Research · doi:10.1038/pr.2017.284 · Cited by 225
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism
Ren, A. A., Snellings, D. A., Su, Y. S., Hong, C. C., Castro, M., Tang, A. T., Detter, M. R., Hobson, N., Girard, R., Romanos, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03562-8 · Cited by 201
Beyond PI3Ks: targeting phosphoinositide kinases in disease
Burke, J. E., Triscott, J., Emerling, B. M., & Hammond, G. R. V. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00582-5 · Cited by 156
Angiopoietin–TIE2 feedforward circuit promotes PIK3CA-driven venous malformations
Kraft, M., Schoofs, H., Petkova, M., Andrade, J., Grosso, A. R., Benedito, R., De Roo, A.-K., Boon, L. M., Vikkula, M., Kapp, F. G., et al. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00655-9 · Cited by 28
Metadata
- Authors
- Castillo, S. D., Tzouanacou, E., Zaw-Thin, M., Berenjeno, I. M., Parker, V. E. R., Chivite, I., Milà-Guasch, M., Pearce, W., Solomon, I., Angulo-Urarte, A., Figueiredo, A. M., Dewhurst, R. E., Knox, R. G., Clark, G. R., Scudamore, C. L., Badar, A., Kalber, T. L., Foster, J., Stuckey, D. J., David, A. L., Phillips, W. A., Lythgoe, M. F., Wilson, V., Semple, R. K., Sebire, N. J., Kinsler, V. A., Graupera, M., & Vanhaesebroeck, B.
- Venue
- Science Translational Medicine
- Published
- 2016-03-30
- Volume
- 8
- Issue
- 332
- Pages
- 332ra43-332ra43
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2332154751
- Cited by
- 192
- References
- 4
- FWCI
- 23.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.